All Title Author
Keywords Abstract

HCG Found in WHO Tetanus Vaccine in Kenya Raises Concern in the Developing World

DOI: 10.4236/oalib.1103937, PP. 1-32

Keywords: Anti-Fertility Measures, Beta-Human Chorionic Gonadotropin, Birth-Control Vaccine, Population Control Programs

Full-Text   Cite this paper   Add to My Lib


In 1993, WHO announced a “birth-control vaccine” for “family planning”. Published research shows that by 1976 WHO researchers had conjugated tetanus toxoid (TT) with human chorionic gonadotropin (hCG) producing a “birth-control” vaccine. Conjugating TT with hCG causes pregnancy hormones to be attacked by the immune system. Expected results are abortions in females already pregnant and/or infertility in recipients not yet impregnated. Repeated inoculations prolong infertility. Currently WHO researchers are working on more potent anti-fertility vaccines using recombinant DNA. WHO publications show a long-range purpose to reduce population growth in unstable “less developed countries”. By November 1993 Catholic publications appeared saying an abortifacient vaccine was being used as a tetanus prophylactic. In November 2014, the Catholic Church asserted that such a program was underway in Kenya. Three independent Nairobi accredited biochemistry laboratories tested samples from vials of the WHO tetanus vaccine being used in March 2014 and found hCG where none should be present. In October 2014, 6 additional vials were obtained by Catholic doctors and were tested in 6 accredited laboratories. Again, hCG was found in half the samples. Subsequently, Nairobi’s AgriQ Quest laboratory, in two sets of analyses, again found hCG in the same vaccine vials that tested positive earlier but found no hCG in 52 samples alleged by the WHO to be vials of the vaccine used in the Kenya campaign 40 with the same identifying batch numbers as the vials that tested positive for hCG. Given that hCG was found in at least half the WHO vaccine samples known by the doctors involved in administering the vaccines to have been used in Kenya, our opinion is that the Kenya “anti-tetanus” campaign was reasonably called into question by the Kenya Catholic Doctors Association as a front for population growth reduction.


[1]  Catholic Health Commission of Kenya (2017).
[2]  (2014) Kenya Conference of Catholic Bishops. Press Statement by the Kenya Conference of Catholic Bishops.
[3]  Nzwili, F. (2014) Kenya’s Catholic Bishops: Tetanus Vaccine Is Birth Control in Disguise. The Washington Post.
[4]  Talwar, G.P. (1976) Immunology in the Field of Contraception, including Review of Current Status. Regional Centre for Documentation on Human Reproduction, Family Planning and Population Dynamics, World Health Organization, Regional Office for South-East Asia.
[5]  Talwar, G.P., Sharma, N.C., Dubey, S.K., Salahuddin, M., Das, C., Ramakrishnan, S., et al. (1976) Isoimmunization against Human Chorionic Gonadotropin with Con-jugates of Processed Beta-Subunit of the Hormone and Tetanus Toxoid. Proceedings of the National Academy of Sciences, 73, 218-222.
[6]  Talwar, G.P. (1979) Recent Advances in Reproduction and Regulation of Fertility. Elsevier Science Ltd., New York.
[7]  Lall, L., Srinivasan, J., Rao, L.V., Jain, S.K., Talwar, G.P. and Chakrabarti, S. (1988) Recombinant Vaccinia Virus Expresses Immunoreactive Alpha Subunit of Ovine Luteinizing Hormone Which Associates with Beta-hCG to Generate Bioactive Dimer. Indian Journal of Biochemistry & Biophysics, 25, 510-514.
[8]  Talwar, G.P. and Raghupathy, R. (1989) Anti-Fertility Vaccines. Vaccine, 7, 97-101.
[9]  Chakrabarti, S., Srinivasan, J., Lall, L., Rao, L.V. and Talwar, G.P. (1989) Expression of Biologically Active Human Chorionic Gonadotropin and Its Subunits by Recombinant Vaccinia Virus. Gene, 77, 87-93.
[10]  Talwar, G.P., Singh, O., Pal, R. and Chatterjee, N. (1992) Anti-hCG Vaccines Are in Clinical Trials. Scand J Immunol Suppl, 11, 123-126.
[11]  Talwar, G.P., Singh, O., Pal, R., Chatterjee, N., Upadhyay, S., Kaushic, C., et al. (1993) A Birth-Control Vaccine Is on the Horizon for Family-Planning. Annals of Medicine, 25, 207-212.
[12]  Mukhopadhyay, A., Mukhopadhyay, S.N. and Talwar, G.P. (1994) Physio-logical Factors of Growth and Susceptibility to Virus Regulating Vero Cells for Optimum Yield of Vaccinia and Cloned Gene Product (Beta-hCG). Journal of Biotechnology, 36, 177-182.
[13]  Talwar, G.P., Singh, O., Pal, R., Chatterjee, N., Sahai, P., Dhall, K., et al. (1994) A Vaccine That Prevents Pregnancy in Women. Proceedings of the National Academy of Sciences of the USA, 91, 8532-8536.
[14]  Giri, D.K. and Talwar, G.P. (1995) Contraceptive Vaccines. Current Science, 68, 423-434.
[15]  Mukhopadhyay, A., Mukhopadhyay, S.N. and Talwar, G.P. (1995) Studies on the Synthesis of βhCG Hormone in Vero Cells by Recombinant Vaccinia Virus. Biotechnology and Bioengineering, 48, 158-168.
[16]  Kaliyaperumal, A., Chauhan, V.S., Talwar, G.P. and Raghupathy, R. (1995) Carrier-Induced Epitope-Specific Regulation and Its Bypass in a Protein-Protein Conjugate. European Journal of Immunology, 25, 3375-3380.
[17]  Srinivasan, J., Singh, O., Chakrabarti, S. and Talwar, G.P. (1995) Targeting Vaccinia Virus-Expressed Secretory Beta Subunit of Human Chorionic Gonadotropin to the Cell Surface Induces Antibodies. Infection and Immunity, 63, 4907-4911.
[18]  Mukhopadhyay, A., Talwar, G.P. and Mukhopadhyay, S.N. (1996) Studies on the Synthesis of βhCG Hormone in Vero Cells by Recombinant Vaccinia Virus. Biotechnology and Bioengineering, 50, 228.
[19]  Talwar, G. (1997) Vaccines for Control of Fertility and Hormone-Dependent Cancers. Immunology and Cell Biology, 75, 184-189.
[20]  Talwar, G.P. (1997) Fertility Regulating and Immunotherapeutic Vaccines Reaching Human Trials Stage. Human Reproduction Update, 3, 301-310.
[21]  Purswani, S. and Talwar, G.P. (2011) Development of a Highly Immunogenic Recombinant Candidate Vaccine against Human Chorionic Gonadotropin. Vaccine, 29, 2341-2348.
[22]  Nand, K.N., Gupta, J.C., Panda, A.K., Jain, S.K. and Talwar, G.P. (2015) Priming with DNA Enhances Considerably the Immunogenicity of hCG β-LTB Vaccine. American Journal of Reproductive Immunology, 74, 302-308.
[23]  Talwar, G.P. (2013) Making of a Vaccine Preventing Pregnancy without Impairment of Ovulation and Derangement of Menstrual Regularity and Bleeding Profiles. Contraception, 87, 280-287.
[24]  Talwar, G.P., et al. (2014) Making of a Unique Birth Control Vaccine against hCG with Additional Potential of Therapy of Advanced Stage Cancers and Prevention of Obesity and Insulin Resistance. Journal of Cell Science & Therapy, 5, 159.
[25]  Alkema, L., Kantorova, V., Me-nozzi, C. and Biddlecom, A. (2013) National, Regional, and Global Rates and Trends in Contraceptive Prevalence and Unmet Need for Family Planning between 1990 and 2015: A Systematic and Comprehensive Analysis. The Lancet, 381, 1642-1652.
[26]  Talwar, G.P., Gupta, J.C., Rulli, S.B., Sharma, R.S., Nand, K.N., Bandivdekar, A.H., et al. (2015) Advances in Development of a Contraceptive Vaccine against Human Chorionic Gonadotropin. Expert Opinion on Biological Therapy, 15, 1183-1190.
[27]  Gupta, A. (2001) High Expression of Human Chorionic Gonadotrophin Beta-Subunit Using a Synthetic Vaccinia Virus Promoter. Journal of Molecular Endocrinology, 26, 281-287.
[28]  Rout, P.K. and Vrati, S. (1997) Oral Immunization with Recombinant Vaccinia Expressing Cell-Surface-Anchored βhCG Induces Anti-hCG Antibodies and T-Cell Proliferative Response in Rats. Vaccine, 15, 1503-1505.
[29]  Walther, W. and Stein, U. (2000) Viral Vectors for Gene Transfer: A Review of Their Use in the Treatment of Human Diseases. Drugs, 60, 249-271.
[30]  Xie, Y.C., Hwang, C., Overwijk, W., Zeng, Z., Eng, M.H., Mule, J.J., et al. (1999) Induction of Tumor Antigen-Specific Immunity in Vivo by a Novel Vaccinia Vector Encoding Safety-Modified Simian Virus 40 T Antigen. Journal of the National Cancer Institute, 91, 169-175.
[31]  Smith, S. (2016) Catholic Doctors Claim UN Aid Groups Sterilized 1 Million Kenyan Women with Anti-Fertility-Laced Tetanus Vaccinations. CP World.
[32]  Correa Diaz, A.M. and Valencia Arias, A. (2016) Social Responsibility and Ethics in Medical Health. Ratio Juris, 11, 73-89.
[33]  Casey, M.J., O’Brien, R., Rendell, M. and Salzman, T. (2012) Ethical Dilemma of Mandated Contraception in Pharmaceutical Research at Catholic Medical Institutions. The American Journal of Bioethics, 12, 34-37.
[34]  Bonebrake, R., Casey, M.J., Huerter, C., Ngo, B., O’Brien, R. and Rendell, M. (2008) Ethical Challenges of Pregnancy Prevention Programs. Cutis, 81, 494-500.
[35]  Etchells, E., Sharpe, G., Walsh, P., Williams, J.R. and Singer, P.A. (1996) Bioethics for Clinicians: 1. Consent. CMAJ, 155, 177-180.
[36]  Newton-Howes, P.A., Bedford, N.D., Dobbs, B.R. and Frizelle, F.A. (1998) Informed Consent: What Do Patients Want to Know? New Zealand Medical Journal, 111, 340-342.
[37]  Nisselle, P. (1993) The Right to Know—The Need to Disclose. Australian Family Physician, 22, 374-377.
[38]  Miziara, I.D. (2013) ética para clínicos e cirurgioes: Consentimento. Revista da Associacao Médica Brasileira, 59, 312-315.
[39]  Guseinov, A.A. (2013) The Golden Rule of Morality. Russian Studies in Philosophy, 52, 39-55.
[40]  Corazzini, K.N., Lekan-Rutledge, D., Utley-Smith, Q., Piven, M.L., Colón-Emeric, C.S., Bailey, D., et al. (2005) The Golden Rule: Only a Starting Point for Quality Care. Director, 14, 255-293.
[41]  Ness, G.D. (1994) Worlds Apart 2: Thailand and the Philippines. Heroes and Villains in an Asian Population Drama. People Planet, 3, 24-26.
[42]  (1995) Tiff over Anti-Tetanus Vaccine Now Erupted into Battle. International/ Philippines. Vaccine Wkly, 11-13.
[43]  (1994) Philippines. Church vs. State: Fidel Ramos and Family Planning Face “Catholic Power.” Asiaweek, 21-22.
[44]  Kenya Catholic Church Tetanus Vaccine Fears “Unfounded.” BBC News.
[45]  West, T. (2014) Kenyan Doctors Find Anti-Fertility Agent in Tetanus Vaccine? Catholic Church Says Yes. The Inquisitr News.
[46]  Liu, R., Li, X., Xiao, W. and Lam, K.S. (2017) Tumor-Targeting Peptides from Combinatorial Libraries. Advanced Drug Delivery Reviews, 110, 13-37.
[47]  Zhang, X. and Xu, C. (2011) Application of Reproductive Hormone Peptides for Tumor Targeting. Current Pharmaceutical Biotechnology, 12, 1144-1152.
[48]  Rivero-Muller, A., Vuorenoja, S., Tuominen, M., Waclawik, A., Brokken, L.J.S., Ziecik, A.J., et al. (2007) Use of Hecate-Chorionic Gonadotropin Beta Conjugate in Therapy of Lutenizing Hormone Receptor Expressing Gonadal Somatic Cell Tumors. Molecular and Cellular Endocrinology, 269, 17-25.
[49]  Konishi, I., Kuroda, H. and Mandai, M. (1999) Review: Gonadotropins and Development of Ovarian Cancer. Oncology, 57, 45-48.
[50]  Talwar, G.P. (2011) Progress in Vaccinology. In: Talwar, G.P., Ed., Springer-Verlag, Berlin and Heidelberg GmbH & Co. K.
[51]  Lonergan, P., Forde, N. and Spencer, T.E. (2016) Progesterone and Conceptus-De- rived Factors Important for Conceptus Survival and Growth. Animal Reproduction, 13, 143-152.
[52]  Andersen, C.Y. and Andersen, K.V. (2014) Improving the Luteal Phase after Ovarian Stimulation: Reviewing New Options. Reproductive BioMedicine Online, 28, 552-559.
[53]  Andersen, C.Y., Fischer, R., Giorgione, V. and Kelsey, T.W. (2016) Micro-Dose hCG as Luteal Phase Support without Exogenous Progesterone Administration: Mathematical Modelling of the hCG Concentration in Circulation and Initial Clinical Experience. Journal of Assisted Reproduction and Genetics, 33, 1311-1318.
[54]  Macklon, N.S. (2002) Conception to Ongoing Pregnancy: The “Black Box” of Early Pregnancy Loss. Human Reproduction Update, 8, 333-343.
[55]  Talwar, G.P., Singh, O.M., Gupta, S.K., Hasnain, S.E., Pal, R., Majumbar, S.S., et al. (1997) The HSD-hCG Vaccine Prevents Pregnancy in Women: Feasibility Study of a Reversible Safe Contraceptive Vaccine. American Journal of Reproductive Immunology, 37, 153-160.
[56]  Rabaut, M. (2016) The Eliminate Project—Kiwanis Eliminating Mater-nal/Neonatal Tetanus.
[57]  Roper, M.H., Vandelaer, J.H. and Gasse, F.L. (2007) Maternal and Neonatal Tetanus. The Lancet, 370, 1947-1959.
[58]  Demicheli, V., Barale, A. and Rivetti, A. (2015) Vaccines for Women for Preventing Neonatal Tetanus. In: The Cochrane Collaboration, Ed., Cochrane Database of Systematic Reviews, John Wiley & Sons, Ltd., Chichester.
[59]  Elimination of Maternal and Neonatal Tetanus|Health. In: UNICEF.
[60]  WHO|Maternal and Neonatal Tetanus (MNT) Elimination. In: WHO.
[61]  Bryant, L., Carver, L., Butler, C.D. and Anage, A. (2009) Climate Change and Family Planning: Least Developed Countries Define the Agenda. Bulletin of the World Health Organization, 87, 852-857.
[62]  AgriQ Quest, Ltd. (2015) Presentation [PowerPoint in PDF format] to Joint Committee of Experts on Tetanus Toxoid Vaccine Testing. Nairobi, 1-14.
[63]  AgriQ Quest Ltd. Laboratory Analysis Report for the Health Commission, Kenya Conference of Catholic Bishops, Nairobi. Nairobi, 1-20.
[64]  AgriQ Quest Ltd. (2015) Laboratory Analysis Report for the Joint Committee of Experts on Tetanus Toxoid Vaccine Testing: The Ministry of Health and Kenya Catholic Health Commision. Nairobi, 1-32.
[65]  Szabo, A. (1958) “Deiknymi’ [Greek δε?κνυμι] as a Mathematical Expression for “to Prove” [Deikniymi, als mathematischer Terminus für beweisen]. Maia, 106-131.
[66]  USAID Family Planning Program Timeline: Before 1965 to the Present|US Agency for International Development.
[67]  (2016) Planned Parenthood. Wikipedia, the Free Encyclopedia.
[68]  Population|United Nations.
[69]  National Security Council (1975) National Security Study Memorandum 200: The Kissinger Report. 123.
[70]  National Security Council. NSSM 200 The Kissinger Report: Implications of Worldwide Population Growth for U.S. Security and Overseas Interests; The 1974 National Security Study Memorandum. Declassified December 31, 1980, Released to Public 1989. Suzeteo Enterprises; 2014.
[71]  Gates, B. (2010) Bill Gates: Innovating to Zero!|TED Talk|
[72]  WHO Special Programme of Research. Fertility Regulating Vaccines?: Report of a Meeting between Women’s Health Advocates and Scientists to Review the Current Status of the Development of Fertility Regulating Vaccines, Geneva, 17-18 August 1992. World Health Organization, Geneva, Report No. 49117.
[73]  Higgins, A.G. (2010) Gates Makes $10 Billion Vaccines Pledge— In:
[74]  Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines|Bill & Melinda Gates Foundation—Bill & Melinda Gates Foundation.$10-Billion-in-Call-for-Decade-of-Vaccines
[75]  Engelman, P.C. (2011) A History of the Birth Control Movement in America. Praeger, Santa Barbara.
[76]  Margaret Sanger: The Mike Wallace Interview.
[77]  NOW with Bill Moyers. Transcript. Bill Moyers Interviews Bill Gates. 5.09.03|PBS. NOW: Science & Health.
[78]  World Health Organization (2006) Tetanus Vaccine: WHO Position Paper. Weekly Epidemiological Record, 81, 197-208.
[79]  Despite Progress, NT Elimination Efforts Need Stepping up. International/Neonatal Tetanus. Vaccine Wkly, 12-13.
[80]  Tetanus Vaccine May Be Laced with Anti-Fertility Drug. International/Developing Countries. Vaccine Wkly, 9-10.
[81]  Clark, G. (2015) David Morley and Dr. John Button: Just $2.18 Can Save a Baby from an Awful Death|The Province. The Province. British Columbia.
[82]  England, C. (2014) Fertility Regulating Vaccines. In: The Liberty Beacon.
[83]  Talwar, G.P. (1988) Birth Control Vaccine. US4780312 A.
[84]  Galazka, A.M. (1993) The Immunological Basis for Immunization Series, Module 3: Tetanus. World Health Organization.
[85]  Pletz, J., Sánchez-Bayo, F. and Tennekes, H.A. (2016) Dose-Response Analysis Indicating Time-Dependent Neurotoxicity Caused by Organic and Inorganic Mercury—Implications for Toxic Effects in the Developing Brain. Toxicology, 347-349, 1-5.
[86]  Hunt, D.L., Rai, S.N. and Li, C.-S. (2008) Summary of Dose-Response Modeling for Developmental Toxicity Studies. Dose-Response, 6.
[87]  Guimaraes, L.E., Baker, B., Perricone, C. and Shoenfeld, Y. (2015) Vaccines, Adjuvants and Autoimmunity. Pharmacological Research, 100, 190-209.
[88]  Poland, G.A., Kennedy, R.B., McKinney, B.A., Ovsyannikova, I.G., Lambert, N.D., Jacobson, R.M. and Oberg, A.L. (2013) Vaccinomics, Adversomics, and the Immune Response Network Theory: Individualized Vaccinology in the 21st Century. Seminars in Immunology, 25, 89-103.
[89]  Tomljenovic, L. and Shaw, C.A. (2011) Aluminum Vaccine Adjuvants: Are They Safe? Current Medicinal Chemistry, 18, 2630-2637.
[90]  Shaw, C.A., Li, D. and Tomljenovic, L. (2014) Are There Negative CNS Impacts of Aluminum Adjuvants Used in Vaccines and Immunotherapy? Immunotherapy, 6, 1055-1071.
[91]  Shaw, C.A. (2017) Neural Dynamics of Neurological Disease. John Wiley & Sons, Inc.
[92]  Kenya Catholic Doctors Association. Catholic Church Warning: Neonatal Tetanus Vaccine by WHO Is DEADLY and Bad for Women Reproductivity. Kenya Today: News and Analysis. @News.KenyaToday.
[93]  Kenya. 2016.
[94]  50 States in Square Miles from NETSTATE.COM.
[95]  Chard, T. (1992) Pregnancy Tests—A Review. Human Reproduction, 7, 701-710.
[96]  Romero, R., Erez, O., Maymon, E., Chaemsaithong, P., Xu, Z., Pacora, P., et al. (2017) The Maternal Plasma Proteome Changes as a Function of Gestational Age in Normal Pregnancy: A Longitudinal Study. American Journal of Obstetrics & Gynecology, 217, 67.e1-21.
[97]  GenWay Biotech, Inc. (2017) Human Chorionic Gonadotropin (hCG) ELISA, Catalog No. 40-101-325020. GenWay Biotech, Inc.
[98]  MP Biomedicals (2017) Human Chorionic Gonadotropin (hCG) Enzyme Immunoassay Test Kit: Catalog Number: 07BC-1027. MP BIOMEDICALS.,%2007BC1027.pdf
[99]  Spengler, M., Adler, M. and Niemeyer, C.M. (2015) Highly Sensitive Ligand-Binding Assays in Pre-Clinical and Clinical Applications: Immuno-PCR and Other Emerging Techniques. Analyst, 140, 6175-6194.
[100]  Exeter Clinical Laboratory. Blood Sciences Test: hCG (Human Chorionic Gonadotrophin). Exeter Clinical Laboratory, 2017.
[101]  abcam. Human Chorionic Gonadotropin Beta ELISA Kit (ab108638). abcam; 2017.
[102]  Sig-ma-Aldrich. Human Chorionic Gonadotropin (hCG) ELISA, Catalog Number SE120063. Sigma-Aldrich; 2017.
[103]  Roberge, L.F. (1993) Abortifacient Vaccines Loom as New Threat. HLI Reports. 11.11. Gaithersburg, 1-2.
[104]  Roberge, L.F. (1995) Abortifacient Vaccines: Technological Update, Hazards, and Christian Response. The Linacre Quarterly, 62, 67-75.
[105]  Roberge, L.F. (1996) Abortifacient Vaccines: Technological Update, Hazards, and Pro-Life Appraisal. Faith & Reason. Christendom Press, Front Royal, 109-125.
[106]  Miller, J.A. (2017) Are New Vaccines Laced with Birth-Control Drugs? HLI Reports. 13.8. Gaithersburg.
[107]  Naz, R.K., Sacco, A., Singh, O., Pal, R. and Talwar, G.P. (1995) Development of Contraceptive Vaccines for Humans Using Antigens Derived from Gametes (Spermatozoa and Zona Pellucida) and Hormones (Human Chorionic Gonadotrophin): Current Status. Human Reproduction Update, 1, 1-18.
[108]  Talwar, G.P., Ed. (1988) Contraception Research for Today and the Nineties. Springer, New York.
[109]  Miller, J.A. (1995) Were Tetanus Vaccines Laced with Birth-Control Drugs? Human Life International, 13.


comments powered by Disqus